Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 14Neoplasms 7Endometrial Neoplasms 6Lung Neoplasms 5Melanoma 4Head and Neck Neoplasms 4Colonic Neoplasms 4Esophageal Neoplasms 3Uterine Cervical Neoplasms 2Solitary Pulmonary Nodule 2Multiple Pulmonary Nodules 2Lymphedema 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Vulvar Neoplasms 1Uterine Neoplasms 1Thyroid Neoplasms 1Suspected Central Nervous System Tumors 1Stomach Neoplasms 1Skull Base Neoplasms 1Skin Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Pediatric Patients With Solid Tumors 1

Interventions

Saline Solution 1Negative-Pressure Wound Therapy 1Indocyanine Green 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Graves Disease × Indocyanine Green × Clear all
NCT03969108 2020-03-27

Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment

University Health Network, Toronto

Phase 4 Completed
10 enrolled
Head & Neck

Goiter, Graves Disease, Hypoparathyroidism, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡